What have we learned from observational studies and clinical trials of mild to moderate COPD?
Abstract Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. It is well established that patients with mild to moderate disease represent the majority of patients with COPD, and patients with mild COPD already have measurable physiological impairment w...
Main Authors: | Miriam Barrecheguren, Cruz González, Marc Miravitlles |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0882-0 |
Similar Items
-
Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild–moderate ex-smoker COPD patients with persistent oxidative stress
by: Fratta Pasini AM, et al.
Published: (2016-07-01) -
Mild to moderate bleeding: diagnostic and therapeutic paths
by: Caterina Cenci, et al.
Published: (2013-10-01) -
Diagnosing COPD: advances in training and practice – a systematic review
by: Koblizek V, et al.
Published: (2016-04-01) -
Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort
by: Perez-Padilla R, et al.
Published: (2018-10-01) -
EXERCISE LIMITATION IN MILD COPD: THE ROLE OF RESPIRATORY MECHANICAL FACTORS
by: Chin, Roberto Carlos
Published: (2012)